dapi has been researched along with imatinib mesylate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frisa, PS; Goolsby, CL; Gottlieb, MA; Hedley, DW; Jacobberger, JW; Paniagua, M; Shankey, TV; Smith, BL; Sramkoski, RM; Ye, PP | 1 |
1 other study(ies) available for dapi and imatinib mesylate
Article | Year |
---|---|
Immunoreactivity of Stat5 phosphorylated on tyrosine as a cell-based measure of Bcr/Abl kinase activity.
Topics: Antibodies, Monoclonal; Benzamides; Blotting, Western; Cell Line; Cell Line, Tumor; DNA; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Epitopes; Flow Cytometry; Fusion Proteins, bcr-abl; Hematopoietic Stem Cells; Humans; Imatinib Mesylate; Immunoblotting; Indoles; Inhibitory Concentration 50; Interleukin-2; Interleukin-4; K562 Cells; Kinetics; Methanol; Microscopy, Fluorescence; Milk Proteins; Phosphorylation; Piperazines; Protein Binding; Pyrimidines; Signal Transduction; Spectrometry, Fluorescence; STAT5 Transcription Factor; Time Factors; Trans-Activators; Tumor Suppressor Proteins; Tyrosine | 2003 |